CClinicalTrials.gg
CompletedNCT05185193Updated Jan 11, 2022

Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency

An interventional study of radiofrequency and sham stimulation in Idiopathic Edema, sponsored by Pusan National University Yangsan Hospital. Completed at 1 site in Korea, Republic of. Open to female participants aged 19 Years to 72 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-11.

Sponsored by Pusan National University Yangsan Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jun 2020, registered Jun 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
19 Years to 72 Years
Sex
Female
01

Study summary

The purpose of this study is to verify the efficacy and safety of the radiofrequency stimulation compared to the sham stimulation in reducing lower extremity edema in adult women with idiopathic edema.

Read the detailed description

In this study, based on the characteristics of radiofrequency, it was hypothesized that radiofrequency could have an effect on the reduction of lower extremity edema and prevention of fatigue. The occurrence of edema is interpreted as a problem that blood circulation is not smooth due to increased inflow of body fluid, and therefore the degree of edema is also used as an indicator of blood circulation.

Therefore, in this study, based on the principle that radiofrequency promotes phosphorylation and blood circulation, the purpose of this study is to investigate whether radiofrequency treatment is effective in reducing edema of the lower extremities and changing body heat in the lower extremities compared to the gastric stimulation device through exploratory research.

02

Conditions studied

  • Idiopathic Edema

Browse trials for

03

In context

Edema

825 studies on the registry are indexed under Edema; 91 are open to participants now.

This study's enrollment of 15 is below the median of 52 across 601 interventional studies indexed under Edema.

Browse Edema studies →

Lead sponsor

Pusan National University Yangsan Hospital is the lead sponsor of 106 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 72 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Women between the ages of 19 and 72
  2. Those who are not likely to menstruate during the trial treatment period (3 days) (females within 8 to 18 days after the onset of menstruation)
  3. Those who meet the diagnostic criteria for idiopathic edema (McKendry criteria score of 15 or higher)
  4. Those who show a weight change of 1.4 kg or more between morning and night measurements
  5. Those who have a difference of 1cm or more from the ankle or 2cm or more from the calf when measuring the circumference in the morning and evening
  6. Those who voluntarily agree to participate in this clinical trial and sign the consent form

Exclusion criteria

Exclusion Criteria:

  1. In the case of using a heart rate control device such as a metallic substance in the human body
  2. During menstruation or if there is a possibility of pregnancy
  3. If you have heart disease
  4. If you have liver or kidney disease
  5. If there is bleeding or internal bleeding from wounds or surgery
  6. For hypertensive patients
  7. For epilepsy patients
  8. If you are taking weight loss or health-related drugs/health functional foods
  9. In the case where it is judged by the principal investigator that participation in this study is not appropriate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    radiofrequency stimulation

    Participants received radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).

    Device: radiofrequency

  • Sham comparator
    sham stimulation

    Participants received a sham stimulation similar to a radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).

    Device: sham stimulation

Interventions

  • Deviceradiofrequency

    Radiofrequency of 9.50v, 218.5mA and 2.076W is applied once a day for 30 minutes, a total of 3 times

    Also known as: high frequency

  • Devicesham stimulation

    The appearance is the same as the medical device for clinical trials, and when applied, the sound and the amount of light visible from the outside are designed to be the same as the medical device for clinical trials. The external light was the same, and only the high frequency that stimulates the dermis was blocked. The sham device was applied once a day for 30 minutes, a total of 3 times.

06

What researchers measure

Primary outcomes

  1. Change of Circumference(the lower calf at 7 cm proximal to the midpoint of the medial malleolus, behind the medial malleolus, and the dorsum of the foot)

    Circumference was measured using a tape measure at three anatomical locations.

    Time frame: Changes of circumference before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

Secondary outcomes

  1. Change of Volume

    The leg volume test is measured using Volumeters (Deluxe Foot) of Jeongdo BNP Co., Ltd. in Korea. Measure using the principle of overflowing, fill a cylinder with a diameter of 30cm and a height of 30cm with water, put one leg in the cylinder with the ankle bent at 90 degrees, and take the overflowing water and measure the amount in ml.

    Time frame: Changes of volume before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  2. digital infrared thermal imaging(DITI)

    Measure the subject's leg body heat using DITI.

    Time frame: Changes of body heat before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  3. Visual analog scale(VAS)

    Discomfort VAS is used to measure the degree of discomfort for lower extremity edema after application of the device. And 0 indicates no discomfort at all, and 10 indicates the most severe discomfort imaginable.

    Time frame: Changes of VAS score before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  4. weight

    Measure the participant's weight (kg) using a scale.

    Time frame: Changes of weight before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

07

Study locations

1 site
  • Pusan national university Yangsan Hospital
    Gyeongsang, Yangsan 50610, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05185193
Lead sponsor
Pusan National University Yangsan Hospital
Responsible party
Yong-il Shin (Professor, Pusan National University Yangsan Hospital) — Principal investigator
First posted
Jan 11, 2022
Start date
Jun 30, 2020
Primary completion
Apr 21, 2021
Completion
May 21, 2021
Last update
Jan 11, 2022

Study contacts

Young-Il Shin
principal investigator · Pusan National University Yangsan Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion